Related Experiment Videos
In vitro evaluation on contact sensitivity from DNCB and DNBS using lymphocyte blastogenesis response test
Sangyo Igaku. Japanese Journal of Industrial Health
|November 1, 1991
Summary
This study developed an in vitro model to predict contact allergy. Lymphocyte blastogenesis assays showed that 2,4-dinitrobenzene sulfonic acid sodium salt (DNBS) effectively identified sensitization potential, indicating a useful predictive tool for sensitizers.
Area of Science:
- Immunotoxicology
- Dermatology
- Predictive Toxicology
Background:
- Contact allergy assessment traditionally relies on animal models.
- Developing reliable in vitro methods is crucial for ethical and efficient testing.
- Sensitizers like 1-chloro-2,4-dinitrobenzene (DNCB) are known allergens.
Purpose of the Study:
- To establish and validate an in vitro predictive model for contact allergic potential.
- To assess the efficacy of different challenge agents in detecting sensitization.
- To investigate cross-sensitivity between DNCB and DNBS.
Main Methods:
- Guinea pigs were sensitized with DNCB.
- Lymph node cells were cultured with various antigens (DNCB, DNBS, DNCB+EC, DNBS+EC, DNP-EC).
- Lymphocyte blastogenesis was measured via 5H-thymidine uptake.
Main Results:
- Lymphocytes from sensitized guinea pigs showed significantly higher blastogenesis responses.
- 2,4-dinitrobenzene sulfonic acid sodium salt (DNBS) induced the strongest response.
- Successful in vitro challenge was achieved with sufficient lymphocyte numbers, including DNCB alone.
- Cross-sensitivity between DNCB and DNBS was confirmed in vitro and in vivo.
Conclusions:
- The developed in vitro assay is a valuable tool for predicting contact sensitivity.
- The assay effectively identifies cross-sensitivity between sensitizers.
- This model offers a promising alternative to traditional animal testing for sensitizer assessment.